Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-25-003807
Filing Date
2025-10-03
Accepted
2025-10-03 17:51:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4146
  Complete submission text file 0000929638-25-003807.txt   6061
Mailing Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142 239-302-1707
Enveric Biosciences, Inc. (Subject) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-53543 | Film No.: 251375197
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4800 MONTGOMERY LANE SUITE 150 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 150 BETHESDA MD 20814 (877) 843-3831
AdvisorShares Trust (Filed by) CIK: 0001408970 (see all company filings)

EIN.: 260636087 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SCHEDULE 13G